Investors / United States / Yu Galaxy
Yu Galaxy
Venture capital · Palo Alto, CA, United States · North America
Yu Galaxy is a Silicon Valley venture capital firm led by founder and managing partner PR Yu, Ph.D. It invests early in companies and stays engaged from seed through IPO, providing capital, strategic guidance, and long-term partnership.
Invests inHealthcare & BiotechAI & Machine LearningCybersecurity
In its own wordshealthtechaispaceroboticswireless powerindustrial automation
Your fit with Yu Galaxy
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsYu Galaxy lists 4 checked portfolio companies on its own site and is named in 4 funding rounds, 2 of them as lead. Its most frequent entry is Series B, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (60%), AI & Machine Learning (20%) and Cybersecurity (20%). 75% of its companies are based in United States. It invests most often alongside Star51 Capital, Bold Capital Partners and Catalio Capital Management.
Counts come from funding rounds that name Yu Galaxy, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 50% |
| Growth | 50% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 0 |
| '25 | 1 | 0 |
| '26 | 2 | 2 |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Star51 Capital | 2 |
| Bold Capital Partners | 1 |
| Catalio Capital Management | 1 |
| EDBI | 1 |
| Eastlink Capital | 1 |
| Eclipse | 1 |
| Genoa Ventures | 1 |
| IDEA Fund Partners | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 60% | 15% |
| AI & Machine Learning | 20% | 18% |
| Cybersecurity | 20% | 4% |
Co-investor network
who it backs companies with, and who they back togetherCompare Yu Galaxy head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Yu Galaxy| Date | Company | Stage |
|---|---|---|
| 8 Jul 2026 | Series C+ Led | |
| 16 Apr 2026 | Series B Led | |
| 10 Jul 2025 | Series B | |
| 11 Dec 2024 | Series C+ |
Round details for Yu Galaxy
Amounts, full round histories and every co-investor in Yu Galaxy's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
4 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Aqtual analyzes tissue biology from a blood draw. | Healthcare & Biotech | Jul 2025Series B | Funding round | |
| Capstan Medical develops and provides a less invasive treatment for heart valve disease using surgical robotics and catheter-based technology. | Healthcare & Biotech | Dec 2024Series C+ | Funding round | |
| InsightFinder develops and provides predictive AI software for site reliability engineering and reliability | AI & Machine LearningCybersecurity | Apr 2026Series B | Funding round | |
| Leo Cancer Care develops and provides radiation therapy solutions, including particle and photon therapy, with a focus on upright patient positioning | Healthcare & Biotech | Jul 2026Series C+ | Funding round |
About this data
site last read 5 Nov 2026- Site
- yugalaxy.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 11 Dec 2024
- Companies checked
- 4
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Yu Galaxy's profile as data
Pull Yu Galaxy's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/yugalaxy.com
# also
GET /v1/firms/yugalaxy.com/portfolio
GET /v1/firms/yugalaxy.com/coinvestors
GET /v1/firms/yugalaxy.com/news